Homepage
Open in app
Sign in
Get started
ZS
Impact where it matters.
Follow
The rare pediatric disease priority review voucher program: A lifeline for patients and a catalyst…
The rare pediatric disease priority review voucher program: A lifeline for patients and a catalyst…
For patients with rare diseases, time is of the essence. Read more about the PRV program.
Jason Yaffe
Sep 16
Precision medicine’s patient-centric future: Insights from World Clinical Biomarkers & CDx…
Precision medicine’s patient-centric future: Insights from World Clinical Biomarkers & CDx…
Last week’s conference in Boston left us inspired about the rapid advancements in precision medicine, read more.
Roveiza Irfan
Sep 13
Generative AI adoption amongst pharmaceutical industry leadership in portfolio analytics
Generative AI adoption amongst pharmaceutical industry leadership in portfolio analytics
Learn about current uses, challenges and future potential of AI, particularly generative AI, within portfolio teams.
Shilpi Mathrani
Sep 9
Helping more people get the care they need with digital health
Helping more people get the care they need with digital health
Pharmaceutical companies are increasingly looking for ways to close health disparities to help more people get the healthcare they need.
Elyse Fretz
Aug 30
How to drive innovation in times of uncertainty: An interview with Priya Nagarajan, Bayer, global…
How to drive innovation in times of uncertainty: An interview with Priya Nagarajan, Bayer, global…
Discover innovative ideas with Priya Nagarajan, global cell and gene therapy intelligence lead at Bayer.
Mei Chee Lim
Aug 29
Stepping into “new-age” therapeutic area strategy
Stepping into “new-age” therapeutic area strategy
By: Ryan Wong , Catherine Kuah , Ashley John , Sarah Jegasothy & Ikuko Tashiro
Ashley John
Aug 25
Adapting to evolving consumer consent laws: Strategies for maintaining a seamless patient support…
Adapting to evolving consumer consent laws: Strategies for maintaining a seamless patient support…
Read about the complexities of state-specific consent laws, the reconsenting process and the need to preserve patient experience.
Falak Kansal
Aug 23
Advancing adult immunization: Exploring the pricing and access landscape for combination vaccines
Advancing adult immunization: Exploring the pricing and access landscape for combination vaccines
Explore pricing and access considerations and deep dive on what may be required to unlock the full potential of adult combination vaccines.
Jennifer Wong
Aug 20
Intentional Design: A comprehensive approach to creating optimal user experiences
Intentional Design: A comprehensive approach to creating optimal user experiences
The world of product design enjoys debating and discussing what the best method is for building ideal customer experiences.
Ross Teague
Aug 14
Unlocking India’s potential: Why medical device companies cannot afford to ignore the India market
Unlocking India’s potential: Why medical device companies cannot afford to ignore the India market
Read about India’s unparalleled opportunities for medical device companies looking to increase their growth in the region.
Ashley John
Aug 14
Master Data Management (MDM) in medical affairs
Master Data Management (MDM) in medical affairs
The medical affairs landscape is changing fast, and engaging healthcare leaders has never been more challenging.
Himanshu Vashishta
Aug 2
Establishing an organizational market access mindset
Establishing an organizational market access mindset
Learn about why senior pharmaceutical leaders would agree that market access challenges have surfaced at the forefront of their priorities,
April P. Semilla
Jul 26
Do I need a tokenization engine capability?
Do I need a tokenization engine capability?
Read about when tokenization is needed and provide clarity on what tokenization is.
Manish Menon
Jul 26
From optional to essential: Life science + patient engagement across the globe today
From optional to essential: Life science + patient engagement across the globe today
In the life sciences industry, patient engagement has evolved from a topic of discussion to a critical business strategy.
Sharon Mandler Suchotliff
Jul 24
About ZS Associates
Latest Stories
Archive
About Medium
Terms
Privacy
Teams